Image may be NSFW.
Clik here to view.
Clik here to view.
PSA population screening is back in favour: here’s why
Five years ago, the idea of national screening programmes for prostate cancer had gone cold. The benefits of PSA (prostate specific antigen) blood testing, introduced as a screening tool in the 1980s,...
View ArticleStopping immunotherapy after two years does not affect NSCLC survival
No overall survival difference was found between patients with non-small cell lung cancer who stopped immune checkpoint inhibitors at two years and those continuing treatment indefinitely. The study,...
View ArticleRise in initiation of immunotherapy at the end of life
Immunotherapy is increasingly being initiated in the month prior to death in patients with stage IV non-small-cell lung cancer, melanoma, and renal cell carcinoma. The US study, published in JAMA...
View Article
More Pages to Explore .....
